MYWOT
Child safety
Confidence
Trustworthiness
Confidence
MALICIOUS CONTENT INDICATORS
Ir.biocept.com most likely does not offer any malicious content.
Secure connection support
HTTPS
Ir.biocept.com provides SSL-encrypted connection.
ADULT CONTENT INDICATORS
Ir.biocept.com most likely does not offer any adult content.
Popular pages
-
Financial Information | Biocept Inc.
The Investor Relations website contains information about Biocept Inc.'s business for stockholders, potential investors, and financial analysts.
-
Biocept Reports 2022 Financial Results | Biocept Inc.
SAN DIEGO--(BUSINESS WIRE)--Apr. 17, 2023-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the 12 months ended ...
-
Biocept Reports Second Quarter 2022 Financial Results | Biocept Inc.
Included first revenue from biopharma collaborator using CNSide™ in their therapeutics clinical trial First site opened for patient enrollment in the FORESEE trial to generate evidence of CNSide’s cli...
-
Biocept Reports First Quarter 2023 Financial Results | Biocept Inc.
SAN DIEGO--(BUSINESS WIRE)--May 10, 2023-- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three months ended...
-
Biocept to Report Third Quarter 2021 Financial Results and Host Investor Conference Call on November
412-902-4109 A live webcast of the call will be available at https://ir.biocept.com/. The webcast will be archived for 90 days. A replay of the conference call will be available for 48 hours follo...
-
Biocept Reports First Quarter 2021 Financial Results | Biocept Inc.
$17.8 million were driven by RT-PCR COVID-19 testing Initiated full commercial launch of CNSide™ cerebrospinal fluid assay for diagnosing and managing patients with metastatic cancer involving the cen...